391 related articles for article (PubMed ID: 30092400)
1. The ACE 2 activator diminazene aceturate (DIZE) improves left ventricular diastolic dysfunction following myocardial infarction in rats.
Castardeli C; Sartório CL; Pimentel EB; Forechi L; Mill JG
Biomed Pharmacother; 2018 Nov; 107():212-218. PubMed ID: 30092400
[TBL] [Abstract][Full Text] [Related]
2. Diminazene aceturate enhances angiotensin-converting enzyme 2 activity and attenuates ischemia-induced cardiac pathophysiology.
Qi Y; Zhang J; Cole-Jeffrey CT; Shenoy V; Espejo A; Hanna M; Song C; Pepine CJ; Katovich MJ; Raizada MK
Hypertension; 2013 Oct; 62(4):746-52. PubMed ID: 23959549
[TBL] [Abstract][Full Text] [Related]
3. Is the cardioprotective effect of the ACE2 activator diminazene aceturate more potent than the ACE inhibitor enalapril on acute myocardial infarction in rats?
Badae NM; El Naggar AS; El Sayed SM
Can J Physiol Pharmacol; 2019 Jul; 97(7):638-646. PubMed ID: 30840489
[TBL] [Abstract][Full Text] [Related]
4. Cardioprotective effects of diminazene aceturate in pressure-overloaded rat hearts.
Macedo LM; Souza ÁP; De Maria ML; Borges CL; Soares CM; Pedrino GR; Colugnati DB; Santos RA; Mendes EP; Ferreira AJ; Castro CH
Life Sci; 2016 Jun; 155():63-9. PubMed ID: 27153779
[TBL] [Abstract][Full Text] [Related]
5. Early administration of Enalapril prevents diastolic dysfunction and ventricular remodeling in rabbits with myocardial infarction.
González GE; Wilensky L; Cassaglia P; Morales C; Gelpi RJ
Cardiovasc Pathol; 2016; 25(3):208-213. PubMed ID: 26897484
[TBL] [Abstract][Full Text] [Related]
6. Stimulation of the ACE2/Ang-(1-7)/Mas axis in hypertensive pregnant rats attenuates cardiovascular dysfunction in adult male offspring.
Bessa ASM; Jesus ÉF; Nunes ADC; Pontes CNR; Lacerda IS; Costa JM; Souza EJ; Lino-Júnior RS; Biancardi MF; Dos Santos FCA; Pedrino GR; Colugnati DB; Mazaro-Costa R; Mendes EP; Castro CH
Hypertens Res; 2019 Dec; 42(12):1883-1893. PubMed ID: 31506648
[TBL] [Abstract][Full Text] [Related]
7. Activation of angiotensin-converting enzyme 2 improves cardiac electrical changes in ventricular repolarization in streptozotocin-induced hyperglycaemic rats.
Coutinho DC; Monnerat-Cahli G; Ferreira AJ; Medei E
Europace; 2014 Nov; 16(11):1689-96. PubMed ID: 24741027
[TBL] [Abstract][Full Text] [Related]
8. Diminazene Aceturate Improves Cardiac Fibrosis and Diastolic Dysfunction in Rats with Kidney Disease.
Velkoska E; Patel SK; Griggs K; Burrell LM
PLoS One; 2016; 11(8):e0161760. PubMed ID: 27571511
[TBL] [Abstract][Full Text] [Related]
9. Beneficial Effects of the Angiotensin-Converting Enzyme 2 Activator Dize in Renovascular Hypertension.
Kangussu LM; de Almeida TCS; Prestes TRR; de Andrade De Maria ML; da Silva Filha R; Vieira MAR; Silva ACSE; Ferreira AJ
Protein Pept Lett; 2019; 26(7):523-531. PubMed ID: 30950337
[TBL] [Abstract][Full Text] [Related]
10. Diminazene aceturate (DIZE) has cellular and in vivo antiarrhythmic effects.
Joviano-Santos JV; Santos-Miranda A; Joca HC; Cruz JS; Ferreira AJ
Clin Exp Pharmacol Physiol; 2020 Feb; 47(2):213-219. PubMed ID: 31643111
[TBL] [Abstract][Full Text] [Related]
11. Clinical aspects of left ventricular diastolic function assessed by Doppler echocardiography following acute myocardial infarction.
Poulsen SH
Dan Med Bull; 2001 Nov; 48(4):199-210. PubMed ID: 11767125
[TBL] [Abstract][Full Text] [Related]
12. Effects of combined inhibition of the Na+-H+ exchanger and angiotensin-converting enzyme in rats with congestive heart failure after myocardial infarction.
Ruetten H; Gehring D; Hiss K; Schindler U; Gerl M; Busch AE; Schaefer S
Br J Pharmacol; 2005 Nov; 146(5):723-31. PubMed ID: 16151439
[TBL] [Abstract][Full Text] [Related]
13. The beneficial effects of angiotensin-converting enzyme II (ACE2) activator in pulmonary hypertension secondary to left ventricular dysfunction.
Chen IC; Lin JY; Liu YC; Chai CY; Yeh JL; Hsu JH; Wu BN; Dai ZK
Int J Med Sci; 2020; 17(16):2594-2602. PubMed ID: 33029102
[TBL] [Abstract][Full Text] [Related]
14. Long-term but not short-term p38 mitogen-activated protein kinase inhibition improves cardiac function and reduces cardiac remodeling post-myocardial infarction.
Kompa AR; See F; Lewis DA; Adrahtas A; Cantwell DM; Wang BH; Krum H
J Pharmacol Exp Ther; 2008 Jun; 325(3):741-50. PubMed ID: 18334667
[TBL] [Abstract][Full Text] [Related]
15. Soluble guanylyl cyclase activation improves progressive cardiac remodeling and failure after myocardial infarction. Cardioprotection over ACE inhibition.
Fraccarollo D; Galuppo P; Motschenbacher S; Ruetten H; Schäfer A; Bauersachs J
Basic Res Cardiol; 2014 Jul; 109(4):421. PubMed ID: 24907870
[TBL] [Abstract][Full Text] [Related]
16. p38 mitogen-activated protein kinase inhibition improves cardiac function and attenuates left ventricular remodeling following myocardial infarction in the rat.
See F; Thomas W; Way K; Tzanidis A; Kompa A; Lewis D; Itescu S; Krum H
J Am Coll Cardiol; 2004 Oct; 44(8):1679-89. PubMed ID: 15489104
[TBL] [Abstract][Full Text] [Related]
17. Diminazene aceturate improves autonomic modulation in pulmonary hypertension.
Rigatto K; Casali KR; Shenoy V; Katovich MJ; Raizada MK
Eur J Pharmacol; 2013 Aug; 713(1-3):89-93. PubMed ID: 23665493
[TBL] [Abstract][Full Text] [Related]
18. Activation of angiotensin-converting enzyme 2 (ACE2) attenuates allergic airway inflammation in rat asthma model.
Dhawale VS; Amara VR; Karpe PA; Malek V; Patel D; Tikoo K
Toxicol Appl Pharmacol; 2016 Sep; 306():17-26. PubMed ID: 27343405
[TBL] [Abstract][Full Text] [Related]
19. Beneficial effects of delayed ivabradine treatment on cardiac anatomical and electrical remodeling in rat severe chronic heart failure.
Milliez P; Messaoudi S; Nehme J; Rodriguez C; Samuel JL; Delcayre C
Am J Physiol Heart Circ Physiol; 2009 Feb; 296(2):H435-41. PubMed ID: 19074674
[TBL] [Abstract][Full Text] [Related]
20. Spironolactone modulates expressions of cardiac mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase 2 and prevents ventricular remodeling in post-infarct rat hearts.
Takeda M; Tatsumi T; Matsunaga S; Hayashi H; Kimata M; Honsho S; Nishikawa S; Mano A; Shiraishi J; Yamada H; Takahashi T; Matoba S; Kobara M; Matsubara H
Hypertens Res; 2007 May; 30(5):427-37. PubMed ID: 17587755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
